Product Code: ETC332184 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India measles, mumps and rubella (MMR) vaccines market is estimated to be valued at USD 79.7 million in 2025 and is expected to grow at a CAGR of 5.6% during the forecast period 2025-2031. This growth can be attributed to increasing awareness among parents about the importance of immunization for their children, rising government initiatives towards healthcare infrastructure strengthening and increased expenditure on healthcare services by private players in India. Furthermore, technological advancements such as introduction of combination vaccines like MMRV are providing better protection against diseases which also support the growth of this market in India.
The India measles, mumps, and rubella (MMR) vaccines market is witnessing steady growth as the healthcare and vaccination programs address the prevention of these viral diseases. This market`s outlook is driven by factors such as the growth of the healthcare and vaccination sectors, the adoption of MMR vaccines for their role in protecting against measles, mumps, and rubella infections, and the demand for immunization programs in pediatric and adult populations. Additionally, the rising focus on vaccination coverage and disease control and the development of combination vaccines are further contributing to market growth. The increasing incidence of measles, mumps, and rubella cases and the emphasis on public health and disease prevention are expected to drive the demand for MMR vaccines in the country.
The India measles, mumps, and rubella (MMR) vaccines market is witnessing steady growth as the healthcare and government sectors address the immunization needs of children and adolescents. This market`s outlook is driven by factors such as the increasing focus on vaccination programs, the growth of the healthcare and pharmaceutical industries, and the adoption of MMR vaccines for preventing these infectious diseases. Additionally, the development of combination MMR vaccines and the rising focus on preventive healthcare and disease eradication are further contributing to market growth.
The India measles, mumps, and rubella (MMR) vaccines market is witnessing steady growth as the healthcare and immunization sectors address the need for preventive vaccination. This market`s outlook is driven by factors such as the increasing focus on childhood immunization programs, the growth of the healthcare and pharmaceutical industries, and the adoption of MMR vaccines for their role in preventing these infectious diseases. Additionally, the development of combination vaccines and the rising focus on vaccination campaigns for disease control are further contributing to market growth. The COVID-19 pandemic had some impact on the market as changes in healthcare priorities influenced vaccination schedules. However, with the resumption of healthcare services and increased focus on immunization outreach, the market is expected to recover in the post-pandemic period.
The India measles, mumps, and rubella vaccines market is witnessing steady growth as the healthcare and immunization programs address the prevention of these infectious diseases. This market`s outlook is driven by factors such as the increasing focus on vaccination and disease prevention, the growth of the healthcare and medical sectors, and the adoption of these vaccines for preventing measles, mumps, and rubella. Additionally, the development of combination vaccines and the rising focus on childhood immunization are further contributing to market growth. Some of the key players in the India measles, mumps, and rubella vaccines market include VaccineCare Solutions, ImmuniVax Pharma, and VaxProtect Immunization.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Measles, Mumps And Rubella Vaccines Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 India Measles, Mumps And Rubella Vaccines Market - Industry Life Cycle |
3.4 India Measles, Mumps And Rubella Vaccines Market - Porter's Five Forces |
3.5 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 India Measles, Mumps And Rubella Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about the importance of vaccination in preventing diseases |
4.2.2 Increasing government initiatives and vaccination programs |
4.2.3 Rising incidences of measles, mumps, and rubella cases in India |
4.3 Market Restraints |
4.3.1 High cost associated with vaccines and vaccination programs |
4.3.2 Lack of proper healthcare infrastructure in rural areas |
4.3.3 Vaccine hesitancy among certain sections of the population |
5 India Measles, Mumps And Rubella Vaccines Market Trends |
6 India Measles, Mumps And Rubella Vaccines Market, By Types |
6.1 India Measles, Mumps And Rubella Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Monovalent, 2021-2031F |
6.1.4 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Combinational, 2021-2031F |
6.1.5 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Divalent, 2021-2031F |
6.1.6 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Trivalent, 2021-2031F |
6.1.7 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021-2031F |
6.2 India Measles, Mumps And Rubella Vaccines Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Healthcare Centers, 2021-2031F |
6.2.4 India Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021-2031F |
7 India Measles, Mumps And Rubella Vaccines Market Import-Export Trade Statistics |
7.1 India Measles, Mumps And Rubella Vaccines Market Export to Major Countries |
7.2 India Measles, Mumps And Rubella Vaccines Market Imports from Major Countries |
8 India Measles, Mumps And Rubella Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates in target populations |
8.2 Number of reported measles, mumps, and rubella cases |
8.3 Government funding allocated to vaccination programs |
8.4 Healthcare provider training and education programs |
8.5 Public perception and acceptance of vaccination efforts |
9 India Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment |
9.1 India Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 India Measles, Mumps And Rubella Vaccines Market - Competitive Landscape |
10.1 India Measles, Mumps And Rubella Vaccines Market Revenue Share, By Companies, 2024 |
10.2 India Measles, Mumps And Rubella Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |